Cita APA

Eslami, G., Mousaviasl, S., Radmanesh, E., Jelvay, S., Bitaraf, S., Simmons, B., . . . Mobarak, S. (2020). The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19. J Antimicrob Chemother.

Chicago Style Citation

Eslami, Gholamali, et al. "The Impact of Sofosbuvir/daclatasvir or Ribavirin in Patients With Severe COVID-19." J Antimicrob Chemother 2020.

Cita MLA

Eslami, Gholamali, et al. "The Impact of Sofosbuvir/daclatasvir or Ribavirin in Patients With Severe COVID-19." J Antimicrob Chemother 2020.